"10.1371_journal.pone.0079145","plos one","2013-11-11T00:00:00Z","Eva C Schulte; Immanuel Stahl; Darina Czamara; Daniel C Ellwanger; Sebastian Eck; Elisabeth Graf; Brit Mollenhauer; Alexander Zimprich; Peter Lichtner; Dietrich Haubenberger; Walter Pirker; Thomas Brücke; Benjamin Bereznai; Maria J Molnar; Annette Peters; Christian Gieger; Bertram Müller-Myhsok; Claudia Trenkwalder; Juliane Winkelmann","Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität, München, Munich, Germany; Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany; Max-Planck Institut für Psychiatrie, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Chair for Genome-Oriented Bioinformatics, Technische Universität München, Life and Food Science Center Weihenstephan, Freising-Weihenstephan, Germany; Paracelsus Elena Klinik, Kassel, Germany; Neurochirurgische Klinik, Georg August Universität, Göttingen, Germany; Department of Neurology, Medical University of Vienna, Vienna, Austria; Institut für Humangenetik, Technische Universität München, Munich, Germany; Department of Neurology, Wilhelminenspital, Vienna, Austria; Center for Molecular Neurology, Department of Neurology, Semmelweis University, Budapest, Hungary; Institute for Epidemiology II, Helmholtz Zentrum München, Munich, Germany; Institute for Genetic Epidemiology, Helmholtz Zentrum München, Munich, Germany; Department of Neurology and Neurosciences, Stanford University, Palo Alto, California, United States of America","Conceived and designed the experiments: ECS DC DCE BMM CT JW. Performed the experiments: ECS IS DC DCE EG. Analyzed the data: ECS IS DC DCE SE PL BMM. Contributed reagents/materials/analysis tools: BM AZ DH WP TB BB MJM AP CG CT. Wrote the paper: ECS IS JW.","The authors have read the journal’s policy and have the following conflicts of interest to declare: Dr. ECS, Mr. IM, Dr. DC, Mr. DCE, Mr. SE and Mrs. EG report no disclosures. Dr. BM received travel compensation from Novartis and Boehringer-Ingelheim, lecturing fees from Orion and Glaxo-Smith-Kline, grant support from GE Healthcare, Boehringer-Ingelheim, Desitin, TEVA-Pharma, and serves as a consultant to Bayer-Schering Pharma and the Michael J. Fox Foundation for Parkinson’s Disease Research. Dr. DH received speaker honoraria from Ipsen Pharma. Dr. WP received speaker honoraria from AOP Orphan Pharma, Medtronic Inc., Novartis, Boehringer-Ingelheim, Abbott Pharm and UCB as well as travel compensation from Ipsen Pharma, Boehringer-Ingelheim, and Medtronic Inc. Dr. BB declares no conflicts of interest. Dr. MJM serves/has served on scientific advisory boards for Genzyme Europe B.V., received speaker honoria from Roche and serves as the Editor-in-Chief of the Hungarian edition of Neurology. Dr. AZ, Dr. TB, Dr. PL, Dr. AP, Dr. CG and Dr. BMM report no disclosures. Dr. CT serves on scientific advisory boards for Boehringer Ingelheim and UCB, has received speaker honoraria from Boehringer Ingelheim, UCB, and Mundipharma as well as travel compensation from UCB, Boehringer-Ingelheim, and Mundipharma. Dr. JW serves on a scientific advisory board for UCB, has received speaker honoraria from UCB and Vifor Pharma. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2013","11","Eva C Schulte","ECS",19,TRUE,6,5,7,3,TRUE,TRUE,FALSE,0,NA,FALSE
